Table 2. Drug-related adverse events by NCI CTC grade.
All (n=17) | |
---|---|
Grade 3 | |
Leucopenia | 1 |
Neutropenia | 3 |
WBC decreased | 1 |
Grade 2 | |
Leucopenia | 2 |
Thrombocytopenia | 2 |
Nausea | 2 |
WBC count decreased | 1 |
Skin disorders | 6 |
Hypotension | 1 |
Grade 1 | |
Fever | 4 |
Thrombocytopenia | 1 |
Headache | 1 |
Skin disorders | 7 |
Folliculitis | 1 |
DLT=dose-limiting toxicity; NCI CTC=National Cancer Institute Common Toxicity Criteria; WBC=white blood cell.
DLT was defined as grade 3 or 4 nonhaematologic toxicities (excluding headache, alopecia, nausea, vomiting, skin reactions, and fever above 40°C for less than 24 h); grade 4 nausea, vomiting, fever above 40°C sustained for more than 24 h; grade 3 or 4 neutropenia associated with complications (e.g. neutropenic fever); grade 4 thrombocytopenia, toxicity-related discontinuation of treatment for more than 1 week within the first two treatment cycles.